BOONTON, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) today announced financial results for the third quarter, 2010 and highlighted progress with the Company’s recent establishment of two specialized strategic business units – Unigene Therapeutics and Unigene Biotechnologies.
